Siemens Healthineers AG

24.99
-0.38 (-1.50%)
At close: Apr 21, 2025, 3:59 PM

Company Description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.

The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies.

The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products.

The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy.

The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions.

It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services.

The company is headquartered in Erlangen, Germany.

Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Siemens Healthineers AG
Siemens Healthineers AG logo
Country DE
IPO Date May 14, 2018
Industry Medical - Devices
Sector Healthcare
Employees 73,100
CEO Dr. Bernhard Montag Ph.D.

Contact Details

Address:
Henkestrasse 127
Erlangen,
DE
Website https://www.siemens-healthineers.com

Stock Details

Ticker Symbol SMMNY
Exchange PNK
Fiscal Year October - September
Reporting Currency USD
CIK Code n/a
CUSIP Number 82622J104
ISIN Number US82622J1043
Employer ID -
SIC Code n/a

Key Executives

Name Position
Dr. Bernhard Montag Ph.D. President, Chief Executive Officer & Chairman of Management Board
Dr. Jochen Schmitz Ph.D. Chief Financial Officer & Member of Management Board
Andre Hartung Head of Imaging
Carsten Bertram Head of Advanced Therapies
Christian Klaussner Executive Vice President of Finance
Darleen Caron Chief Human Resources Officer, Labor Director & Member of Management Board
David C. Pacitti M.B.A. Head of Americas
Elisabeth Staudinger-Leibrecht M.A. Member of Management Board
Marc Koebernick Head of Investor Relations
Sharon J. Bracken Head of Diagnostics

Latest SEC Filings

No SEC filings available.